These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5402966)

  • 41. [Dispensarization and therapy of patients with obliterative endarteritis].
    Prokopishin MV
    Klin Khir (1962); 1967 Feb; 2():73-7. PubMed ID: 5618737
    [No Abstract]   [Full Text] [Related]  

  • 42. Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs.
    Bodzenta-Lukaszyk A; Krupiński K; Dabrowski S; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):479-82. PubMed ID: 2465957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Conduction velocity of the peroneal nerve in obliterative arteriosclerosis of lower limbs].
    Eljasz L
    Pol Tyg Lek; 1973 May; 28(19):682-5. PubMed ID: 4710463
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical and hemodynamic effects of captopril in patients with arterial hypertension and obliterative arteriopathy of the legs].
    Bolognini G; Iezzi Biase G
    Clin Ter; 1986 Feb; 116(4):287-9. PubMed ID: 3516544
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 46. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H; Reuter W; Voigt H; Herrmann W
    Z Gesamte Inn Med; 1989 Feb; 44(3):77-9. PubMed ID: 2728555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Electromyographic studies in obliterative atherosclerosis of the blood vessels of the lower extremities].
    Demina EN
    Klin Med (Mosk); 1983 May; 61(5):44-7. PubMed ID: 6876700
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hemodynamic changes in patients with arteriosclerosis obliterans of the lower extremities after restoration of the circulation].
    Peregudov IG; Sazonov AB; Alen'tev AA; Sukhov VK
    Vestn Khir Im I I Grek; 1989 Jul; 143(7):50-2. PubMed ID: 2595929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological effects of iloprost (ZK 36 374), a stable prostacyclin analogue, in man.
    Ylitalo P; Kaukinen S; Seppäla E; Nurmi AK; Pessi T; Krais T; Vapaatalo H
    Biomed Biochim Acta; 1984; 43(8-9):S399-402. PubMed ID: 6083786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hemorrhagic diathesis in a patient with obliterative arteriosclerosis during treatment with low-molecular dextran].
    Szmidt M; Rozniecki J; Religa H
    Pol Tyg Lek; 1972 Oct; 27(40):1566-8. PubMed ID: 5081828
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of rheopolyglucin in the treatment of obliterative atherosclerosis of the legs].
    Kokhan EP
    Klin Khir (1962); 1975 Nov; (11):65-6. PubMed ID: 1228283
    [No Abstract]   [Full Text] [Related]  

  • 53. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
    Cospite M; Ferrara F; Milio G; Meli F
    Clin Ter; 1984 Apr; 109(2):127-35. PubMed ID: 6234122
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of patients with obliterative diseases of arteries of the lower extremities by intra-arterial administration of the drugs].
    Bogoev DN; Voskanian EA
    Khirurgiia (Mosk); 1979 Jan; (1):64-7. PubMed ID: 759703
    [No Abstract]   [Full Text] [Related]  

  • 55. [Piribedil (TF 871) in the treatment of arteriopathies of the lower extremities].
    Argenteri A; Moia R; Negri L
    Ann Ital Chir; 1979; 51(2):145-55. PubMed ID: 554489
    [No Abstract]   [Full Text] [Related]  

  • 56. [Intra-arterial administration of pyrrolidin-methyl-tetracycline in the treatment of various obliterative angiopathies].
    Del Corso P; Zeme D; Beverelli M
    Clin Ter; 1970 Nov; 55(3):231-8. PubMed ID: 5516887
    [No Abstract]   [Full Text] [Related]  

  • 57. [Novocain-histamine iontophoresis in the treatment of obliterative artheriosclerosis of the lower limbs].
    Darewicz J; Obrzut A
    Pol Tyg Lek; 1967 Oct; 22(40):1524-6. PubMed ID: 6062536
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hemodilution effect on the electrocardiogram and left-ventricular contraction dynamics in patients with obliterative arteriosclerosis].
    Dabrowski A; Daciewicz Z
    Pol Tyg Lek; 1982 Apr; 37(4-5):117-9. PubMed ID: 7111079
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].
    Tardito E; Trezzi M; Papackaralambus D
    Minerva Cardioangiol; 1970 Dec; 18(12):692-705. PubMed ID: 5532336
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II; Guch AA
    Klin Khir (1962); 1994; (7):22-4. PubMed ID: 7823491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.